Journal of Critical Care
Volume 25, Issue 2 , Pages 361.e1-361.e5 , June 2010

Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients

  • Mehmet Turan Inal, MD

      Affiliations

    • Trakya University Faculty of Medicine, Department of Anesthesiology and Reanimation, Edirne 22030, Turkey
    • ,
  • Dilek Memiş, MD

      Affiliations

    • Trakya University Faculty of Medicine, Department of Anesthesiology and Reanimation, Edirne 22030, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +902842357641; fax: +902842357680.
    • ,
  • Beyhan Karamanlıoglu, MD

      Affiliations

    • Trakya University Faculty of Medicine, Department of Anesthesiology and Reanimation, Edirne 22030, Turkey
    • ,
  • Necdet Sut, PhD

      Affiliations

    • Trakya University Faculty of Medicine, Department of Biostatistic, Edirne 22030, Turkey

References 

  1. Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat Rec (Hoboken). 2008;291:714–720
  2. Sakka SG, Bredle DL, Reinhart K, Meier-Hellmann A. Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. J Crit Care. 1999;14:78–83
  3. Bagshaw SM, Bellomo R. The influence of volume management on outcome. Curr Opin Crit Care. 2007;13:541–548
  4. Molnar Z, Mikor A, Leiner T, Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med. 2004;30:1356–1360
  5. Wiedermann CJ. Systematic review of randomized trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med. 2008;8:1
  6. Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, et al. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl. 2004;10:1060–1064
  7. Leevy CM, Smith F, Longueville J, Paumgartner G, Howard MM. Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. JAMA. 1967;200:236–240
  8. Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med. 2000;26:1553–1557
  9. Hsieh CB, Chen CJ, Chen TW, et al. Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients. World J Gastroenterol. 2004;10:2394–2396
  10. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:204–212
  11. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825–1831
  12. Cottis R, Magee N, Higgins DJ. Haemodynamic monitoring with pulse-induced contour cardiac output (PiCCO) in critical care. Intensive Crit Care Nurs. 2003;19:301–307
  13. Lichtwarck-Aschoff M, Zeravik J, Pfeiffer UJ. Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med. 1992;18:142–147
  14. Hofmann D, Thuemer O, Schelenz C, van Hout N, Sakka SG. Increasing cardiac output by fluid loading: effects on indocyanine green plasma disappearance rate and splanchnic microcirculation. Acta Anaesthesiol Scand. 2005;49:1280–1286
  15. Kholoussy AM, Pollack D, Matsumoto T. Prognostic significance of indocyanine green clearance in critically ill surgical patients. Crit Care Med. 1984;12:115–116
  16. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest. 2002;122:1715–1720
  17. Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg. 1996;83:254–261
  18. Asfar P, Kerkeni N, Labadie F, Gouëllo JP, Brenet O, Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Med. 2000;26:1282–1287
  19. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW, Menger MD. Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology. 2002;97:460–470
  20. Dienes HP, Gerharz CD, Wagner R, Weber M, John HD. Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol. 1986;3:223–227
  21. Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth. 1999;82:510–515
  22. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim. 1994;13:301–310
  23. Christidis C, Mal F, Ramos J, Senejoux A, Callard P, Navarro R, et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethyl starch infusions. J Hepatol. 2001;35:726–732

☆ This work was supported by the University of Trakya research grant no. TUBAP 2008/70.

PII: S0883-9441(09)00145-2

doi: 10.1016/j.jcrc.2009.06.013

Journal of Critical Care
Volume 25, Issue 2 , Pages 361.e1-361.e5 , June 2010

Article Tools